Currently Enrolling Studies | Center for Women's Health

Ensayos Clínicos Disponibles en Español:

Tenemos personal que hablan Español. Para obtener más información o saber si usted califica para participar, llame a la línea confidencial de reclutamiento de la Unidad de Investigación Sobre la Salud Femenina al 503-494-3666 o escríbanos a whru@ohsu.edu.

Estudios disponibles en Español:

Embarazo:
- Tenemos estudios disponibles para participantes que están embarazadas. Para obtener más información o saber si usted calificaría para participar, llame a la Unidad de Medicina Materno Fetal (MFMU-por sus iniciales en Ingles) al 503-494-8742 o escribanos a mfmresearch@ohsu.edu.
Uso de insulina inhalada en mujeres embarazadas con GDM (INHALE-GDM)
- Este estudio se está realizando para averiguar qué tan bien la inhalación de insulina puede reducir su azúcar en la sangre después de una comida, comparada con la inyección de insulina estándar administrada con su comida. Creemos que inhalar insulina puede funcionar mejor, pero aún no lo sabemos, por lo que este estudio nos ayudará a averiguarlo. Participarán en el estudio 30 mujeres embarazadas de 5 centros de todo Estados Unidos. PI: Dra. Amy Valent, DO IRB#: 28056

Contraception and birth control

Emergency Contraceptive Disparities Study

This study is being conducted to learn more about why some people are at greater risk for oral emergency contraceptive failure while others are not. We are hoping to find out if genetic differences impact the risk of emergency contraception failure. PI: Alison Edelman, MD, MPH; IRB# 24952

Ulipristal Acetate and Mammographic Density

This study is being conducted to determine if the oral emergency contraceptive pill containing ulipristal acetate (UPA, otherwise known as Ella) decreases breast density on mammograms. The drug used in this study is FDA-approved for emergency contraception but not for use in breast health. PI: Abigail Liberty, M.D.; eIRB#: 28348

Pregnancy and infertility

OHSU CWH Center M randomized trial

The purpose of the study is to learn about ways to promote well-being and reduce stress and depression during pregnancy and after birth. We are hoping to find out how well Center M, a mindfulness-based group intervention for pregnant people delivered via telehealth, can help accomplish these goals. PI: Ellen Tilden, CNM, Ph.D., IRB #29027

Continuous glucose monitoring for management of type 2 diabetes in pregnancy

The purpose of this study is to provide pregnant people with type 2 diabetes an opportunity to participate in a project that will help us understand if using CGM in pregnancy can improve sugars and lower pregnancy complications compared to our current standard blood sugar monitoring using fingersticks. PI: Amy Valent, DO, IRB#: 27883

Assessing the use of wearable activity trackers in a pregnancy cohort

The purpose of this study is to determine the feasibility of assessing physical activity in pregnant patients using wearable activity trackers. We will also collect pilot data on the behavioral impact of wearable activity trackers on physical activity in pregnancy after counseling. PIs: Danielle Prentice, DO and Sherilyn DeStefano, MD, eIRB#: 28457

Clinical Utility of a Predictive Model of Placental Insufficiency

The goal of this study is to better determine which pregnancies are at increased risk of complications like stillbirth, growth restriction, and preeclampsia. We will test a combination of lab tests, ultrasound studies, and risk factors to determine risk. The long-term goal is to use this improved risk assessment to improve monitoring of high risk pregnancies and prevent preventable stillbirths. PI: Karen J. Gibbins, MD, MSCI, eIRB#: 26808

IVIDA2

The purpose of this is to determine the efficacy and safety of treating pregnant patients who have a diagnosis of iron deficiency anemia with an iron infusion compared to oral iron supplements and evaluating the effectiveness of both. Both study treatments are currently used in obstetric practice but have not been adequately compared in pregnancy. PI: Ashley Benson, M.D., M.A., M.S., IRB#: 27128

Pregnancy Data Repository to Assess Management of Type 1 Diabetes with Diabetes Technology (PRAM-T1D)

Purpose of the Study: Help us understand how pregnant people with T1D use health tech to take care of their diabetes. Examples of health tech are glucose sensors (CGM; continuous glucose monitoring) and
insulin pumps. Our goal is to make managing T1D in pregnancy easier. By sharing your T1D pregnancy data, you could help make diabetes health tech work better in the future for people with T1D who become pregnant. PI: Amy Valent, DO

Using Inhaled insulin among pregnant people with GDM. (INHALE-GDM)

This study is being done to find out how well inhaling insulin can lower your blood sugar after a meal compared to the standard insulin injection given with your meal. We believe inhaling insulin may work better but we do not know this yet so this study will help us find out. 30 pregnant people from 5 sites around the U.S. will be in the study. PI: Amy Valent, DO; IRB#: 28056